Vitamin & Herb University
Vitamin Information Minerals Information Dietary Supplement Information Herb Information Drug Herb Interaction Continuing Education Pharmacy
Vitamin & Herb University
Acidophilus

Red Arrow  Facts Red Arrow  Functions
Red Arrow  Toxicity Red Arrow  Dietary Sources
Red Arrow  Drug-Supplement Interaction Red Arrow  Research Summary
Red Arrow  Dosage

Print this page Print this page
Contact an Expert Contact an Expert
Dosage Chart  Dosage Chart

 Facts Topic header down arrow
  • Lactobacillus acidophilus is one of the lactobacillus species that produce lactic acid in the digestive tract.
  • The human digestive system contains more than 400 different bacterial species. The number of bacteria has been estimated to be approximately 1014.
  • The prevalent bacteria in the human adult digestive tract are bacteroides, eubacteria, peptostreptococci, bifidobacteria, enterobacteria, streptococci, lactobaccili, clostridia and staphylococci.
  • Lactobacillus is commercially available in yogurt, fermented milk and capsule form.
Arrow top back to top
 Functions Topic header down arrow
  • L. acidophilus has been suggested to:
    • Improve intestinal motility and relieve constipation
    • Enhance immune function
    • Improve digestibility and increase availability of some dietary nutrients
    • Alleviate lactose intolerance
    • Reduce risk of cancer development
    • Alter allergic response, probably by improving the mucosal barrier function
    • Induce rapid recovery from diarrhea caused by antibiotics and pathogens
    • Inhibit adhesion of pathogens to digestive tract
Arrow top back to top
 Toxicity Topic header down arrow
Not known.
Arrow top back to top
 Dietary Sources Topic header down arrow
Arrow top back to top
 Drug-Supplement Interaction Topic header down arrow
1 2 3

  • Antibiotics may disturb intestinal bacteria, causing diarrhea. Lactobacillus acidophilus may reduce risk of diarrhea.
  • Lactobacillus acidophilus are "friendly" bacteria that help reduce common side effects (i.e. diarrhea) of antibiotic therapy. Taking acidophilus-containing products may be recommended during and after antibiotic therapy.
Information on the relationship between substances and disease is provided for general information, in order to convey a balanced review of the scientific literature. In many cases the relationship between a substance and a disease is tentative and additional research is needed to confirm such a relationship.
Arrow top back to top
 Research Summary Topic header down arrow
Immunity: Lyophilized bifidobacterium bifidum (BB) and lactobacillus acidophilus (LA) were given orally to 15 elderly subjects while a placebo was given to 10 elderly subjects for 28 days. The BB and LA administration significantly reduced the inflammatory infiltration in the colon. A significant increase was observed in the number of cells in the peripheral blood that produces antibodies necessary for immune responses. This trial indicated that daily intake of probiotics modulated immunological and inflammatory reactions in the elderly.4

Adherence of Probiotics: It has been found that probiotic bacteria are able to adhere to the intestinal mucous and therefore provide health benefits to infants, children, and adults suffering from diarrhea. However, the ability to adhere to mucosal lining varies among the different types of probiotic bacteria.5

Helicobacter pylori Infection: The effect of L. acidophilus La1 on H. pylori growth urease activity and adhesion to epithelial cells was determined in-vitro. Subjects infected with H. Pylori were treated with 50 ml of L. acidophilus supernatant four times a day with omeprazole for 14 days. Subjects showed decreased colonization of H. pylori by oral administration of acidophilus supernatant. In-vitro, bacteria supernatant inhibited urease activity and the adhesion of H. pylori to HT-29 cells. The authors concluded that L. acidophilus strains produce an inhibitory activity on H. pylori growth in-vitro and in-vivo.6

Colon Cancer: To identify if L. acidophilus reduced the risk of colon cancer development, F344 rats were fed lyophilized cultures of L. acidophilus and treated with azoxymethane (AOM) to induce aberrant crypt foci (ACF) in the colon. Lyophized probiotics decreased AOM-induction of colonic ACF, crypt multiplicity and number of ACF/cm2 colon. ACF formation was inhibited in a dose-dependent manner. Probiotics like L. acidophilus may help prevent colon cancer development. 7

Renal Failure: Patients undergoing hemodialysis were treated with L. acidophilus (LBA) to alter small bowel bacterial overgrowth (SBBO). The LBA treatment significantly reduced concentrations of toxins and carcinogens in serum such as dimethylamines and nitrosodimethylamine. Nutritional status, serum albumin and body weight were moderately improved. 8
Arrow top back to top
 Dosage Topic header down arrow
About 109 to 1010 live bacteria daily are required in various forms (tablet, yogurt, etc…).
Arrow top back to top
Resources header box
LINKS

Article
test link 2
Print icon Printable Consumer Page
Email icon Product Inquiries


Reference box top left Reference header box help Reference box top right
Reference box side
 View my references
To save references
you must be logged in.
Click Here to log in.
Reference box side
Reference box bottom left Reference box side Reference box bottom right